Peakdata raises over 12 million euros

The Swiss e-health company wants to bring healthcare professionals and pharmaceutical companies together with the help of AI.

The Swiss start-up Peakdata has received 12.1 million euros in a Series A financing round. The round was led by Albion VC, a London-based venture capitalist. Octopus Ventures and Heal Capital were also involved, according to the company.

Peakdata intends to use the money to expand its business and continue to grow. The e-health company was founded in 2018 by data scientists Patrick De Boer and Michael Feldman and aims to use an AI platform to bring pharmaceutical companies together with the right medical professionals.

"To ensure that healthcare professionals are informed about the latest drugs, pharmaceutical companies need to be provided with the latest data about them and their areas of focus," said co-founder Patrick de Boer in a company statement. The information would enable pharmaceutical companies to better connect with the right professionals, which would ultimately have a positive impact on patients. "We are delighted that Albion shares this vision," he says.

Albion VC manages one billion US dollars in venture capital, which is invested in over 50 companies. Albion VC partner Christoph Ruedig is impressed by the founders' determination. "It is of enormous importance for pharmaceutical companies to find the right therapeutic experts and medical professionals for their drugs," he says.